CONMED CORPORATION (CNMD) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $36.41M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $11.88M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $38.16M; Depreciation and amortization (m).
- 2025-03-31: Basis Reported; EBITDA (m); Operating income $15.96M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | $36.41M | (m) | $343.49M | (m) | (m) | (m) | $146.03M | $15.50M | $145.55M | $8.28M |
| 2025-09-30 | Reported | (m) | $11.88M | (m) | $337.93M | (m) | $5.19M* | $53.69M* | $171.81M | $13.90M | $140.34M | $1.41M |
| 2025-06-30 | Reported | (m) | $38.16M | (m) | $342.35M | (m) | $5.73M* | $29.13M* | $154.03M | $14.14M | $136.02M | $8.50M |
| 2025-03-31 | Reported | (m) | $15.96M | (m) | $321.26M | (m) | $3.78M | $41.53M | $143.50M | $12.95M | $148.85M | $1.64M |
| 2024-09-30 | Reported | (m) | $65.71M | (m) | $316.70M | (m) | $3.42M* | $51.20M* | $137.71M | $13.56M | $99.73M | $7.47M |
| 2024-06-30 | Reported | (m) | $47.11M | (m) | $332.10M | (m) | $3.59M* | $43.31M* | $148.37M | $14.10M | $122.52M | $7.54M |
| 2024-03-31 | Reported | (m) | $35.01M | (m) | $312.27M | (m) | $2.04M | $29.12M | $140.31M | $13.59M | $123.36M | $5.71M |
| 2023-09-30 | Reported | (m) | $30.30M | (m) | $304.58M | (m) | $5.39M* | $46.13M* | $136.52M | $12.46M | $125.30M | $4.44M |
| 2023-06-30 | Reported | (m) | $27.42M | (m) | $317.65M | (m) | $4.53M* | $26.67M* | $146.96M | $13.57M | $129.70M | $3.69M |
| 2023-03-31 | Reported | (m) | $12.70M | (m) | $295.47M | (m) | $4.25M | -$3.85M | $140.15M | $12.54M | $130.08M | $625.00K |
| 2022-09-30 | Reported | (m) | $24.25M | (m) | $275.09M | (m) | $6.71M* | $25.89M* | $123.47M | $12.77M | $114.60M | -$30.44M |
| 2022-06-30 | Reported | (m) | $24.46M | (m) | $277.19M | (m) | $5.71M* | $18.74M* | $125.41M | $11.49M | $115.83M | $74.81M |
| 2022-03-31 | Reported | (m) | $22.44M | (m) | $242.33M | (m) | $3.69M | $328.00K | $106.34M | $10.67M | $102.88M | $2.47M |
| 2021-09-30 | Reported | (m) | $26.71M | (m) | $248.83M | (m) | $5.58M* | $21.36M* | $106.52M | $10.86M | $104.74M | $2.49M |
| 2021-06-30 | Reported | (m) | $25.71M | (m) | $255.16M | (m) | $2.99M* | $34.28M* | $113.74M | $11.32M | $104.40M | $3.00M |
| 2021-03-31 | Reported | (m) | $20.08M | (m) | $232.68M | (m) | $3.11M | $22.34M | $104.23M | $10.03M | $98.34M | -$129.00K |
| 2020-09-30 | Reported | (m) | $29.38M | (m) | $237.84M | (m) | $3.29M* | $35.13M* | $104.14M | $9.94M | $94.38M | $10.50M |
| 2020-06-30 | Reported | (m) | -$21.25M | (m) | $157.78M | (m) | $3.75M* | $5.54M* | $85.86M | $8.70M | $84.47M | -$5.34M |
| 2020-03-31 | Reported | (m) | $13.17M | (m) | $214.01M | (m) | $2.83M | $3.72M | $94.85M | $10.12M | $95.87M | -$2.44M |
| 2019-09-30 | Reported | (m) | $20.94M | (m) | $233.59M | (m) | $4.87M* | $36.60M* | $103.48M | $10.98M | $98.19M | $2.47M |
| 2019-06-30 | Reported | (m) | $18.66M | (m) | $238.26M | (m) | $4.98M* | $21.58M* | $107.07M | $11.81M | $100.73M | $803.00K |
| 2019-03-31 | Reported | (m) | $11.64M | (m) | $218.38M | (m) | $4.02M | -$3.92M | $96.94M | $10.57M | $99.23M | -$2.98M |
| 2018-09-30 | Reported | (m) | $11.52M | (m) | $202.31M | (m) | $4.46M* | $4.35M* | $91.68M | $14.12M | $84.98M | $483.00K |
| 2018-06-30 | Reported | (m) | $16.68M | (m) | $212.82M | (m) | $3.51M* | $20.63M* | $96.55M | $9.98M | $89.60M | $2.87M |
| 2018-03-31 | Reported | (m) | $17.28M | (m) | $202.06M | (m) | $3.78M | $25.02M | $92.51M | $7.71M | $84.57M | $1.80M |
| 2017-09-30 | Reported | (m) | $13.47M | (m) | $190.12M | (m) | $3.71M* | $13.43M* | $87.57M | $8.27M | $80.81M | $1.47M |
| 2017-06-30 | Reported | (m) | $12.78M | (m) | $197.15M | (m) | $2.94M* | $16.03M* | $92.50M | $8.04M | $83.83M | $2.25M |
| 2017-03-31 | Reported | (m) | -$2.49M | (m) | $186.57M | (m) | $2.58M | $15.30M | $86.68M | $7.62M | $94.76M | -$2.07M |
| 2016-09-30 | Reported | (m) | $13.85M | (m) | (m) | (m) | $2.77M* | $24.76M* | $83.58M | $8.35M | $79.01M | $2.65M |
| 2016-06-30 | Reported | (m) | $7.68M | (m) | (m) | (m) | $4.88M* | $17.98M* | $91.01M | $8.01M | $86.73M | $1.04M |
| 2016-03-31 | Reported | (m) | $3.54M | (m) | (m) | (m) | $2.79M | -$16.56M | $83.46M | $8.26M | $85.94M | -$968.00K |
| 2015-09-30 | Reported | (m) | $14.84M | (m) | (m) | (m) | $3.69M* | $13.66M* | $75.64M | $6.65M | $72.06M | $4.46M |
| 2015-06-30 | Reported | (m) | $12.42M | (m) | (m) | (m) | $3.72M* | $10.25M* | $87.53M | $7.50M | $73.58M | $3.47M |
| 2015-03-31 | Reported | (m) | $10.95M | (m) | (m) | (m) | $4.06M | $14.81M | $85.66M | $6.54M | $74.79M | $3.18M |
| 2014-09-30 | Reported | (m) | $2.45M | (m) | (m) | (m) | $3.61M* | $14.62M* | $78.55M | $6.91M | $87.06M | -$1.06M |
| 2014-06-30 | Reported | (m) | $15.94M | (m) | (m) | (m) | $4.58M* | $7.89M* | $87.12M | $6.85M | $78.23M | $4.11M |
| 2014-03-31 | Reported | (m) | $17.31M | (m) | (m) | (m) | $4.07M | $17.02M | $79.36M | $6.91M | $78.36M | $7.22M |
| 2013-09-30 | Reported | (m) | $8.80M | (m) | (m) | (m) | $5.35M* | $30.48M* | $83.83M | $7.11M | $73.48M | $1.74M |
| 2013-06-30 | Reported | (m) | $15.65M | (m) | (m) | (m) | $4.07M* | $17.68M* | $90.08M | $6.59M | $77.17M | $4.74M |
| 2013-03-31 | Reported | (m) | $15.87M | (m) | (m) | (m) | $4.13M | $5.47M | $84.33M | $5.69M | $77.72M | $3.75M |
| 2012-09-30 | Reported | (m) | $14.11M | (m) | (m) | (m) | $4.37M* | $27.99M* | $83.97M | $7.08M | $74.06M | $3.45M |
| 2012-06-30 | Reported | (m) | $17.06M | (m) | (m) | (m) | $5.17M* | $25.65M* | $89.96M | $7.19M | $73.71M | $5.21M |
| 2012-03-31 | Reported | (m) | $17.02M | (m) | (m) | (m) | $6.42M | $7.63M | $93.41M | $7.09M | $74.81M | $5.62M |
| 2011-09-30 | Reported | (m) | $15.94M | (m) | (m) | (m) | $4.10M* | $36.49M* | $81.50M | $7.02M | $68.35M | $4.93M |
| 2011-06-30 | Reported | (m) | $16.70M | (m) | (m) | (m) | $4.43M* | $19.52M* | $91.78M | $6.80M | $67.86M | $5.20M |
| 2011-03-31 | Reported | (m) | $17.26M | (m) | (m) | (m) | $4.14M | $20.70M | $87.73M | $7.68M | $70.08M | $5.37M |
| 2010-09-30 | Reported | (m) | $15.20M | (m) | (m) | (m) | $18.02M* | $9.77M* | $83.21M | $7.40M | $66.09M | $3.64M |
| 2010-06-30 | Reported | (m) | $14.78M | (m) | (m) | (m) | (m) | (m) | $87.40M | $6.44M | $71.49M | $4.57M |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | $102.62M | (m) | $1.37B | (m) | $19.81M | $170.69M | $624.25M | $55.88M | $591.97M | $24.06M |
| 2024-12-31 | Reported | (m) | $200.33M | (m) | $1.31B | (m) | $13.08M | $166.97M | $573.98M | $54.43M | $478.28M | $30.61M |
| 2023-12-31 | Reported | (m) | $120.60M | (m) | $1.24B | (m) | $19.03M | $125.35M | $568.50M | $52.60M | $503.04M | $16.37M |
| 2022-12-31 | Reported | (m) | $70.05M | (m) | $1.05B | (m) | $21.79M | $33.37M | $474.23M | $47.15M | $454.04M | $9.72M |
| 2021-12-31 | Reported | (m) | $109.72M | (m) | $1.01B | (m) | $14.87M | $111.77M | $442.60M | $43.56M | $414.75M | $10.56M |
| 2020-12-31 | Reported | (m) | $46.01M | (m) | $862.46M | (m) | $13.01M | $64.53M | $402.16M | $40.47M | $373.82M | -$7.91M |
| 2019-12-31 | Reported | (m) | $79.11M | (m) | $955.10M | (m) | $20.07M | $95.13M | $430.38M | $45.46M | $400.14M | $2.60M |
| 2018-12-31 | Reported | (m) | $71.31M | (m) | $859.63M | (m) | $16.51M | $74.70M | $390.52M | $42.19M | $355.62M | $9.80M |
| 2017-12-31 | Reported | (m) | $46.94M | (m) | $796.39M | (m) | $12.84M | $65.57M | $365.35M | $32.31M | $351.80M | -$26.75M |
| 2016-12-31 | Reported | (m) | $37.68M | (m) | $763.52M | (m) | $14.75M | $39.88M | $355.19M | $32.25M | $338.40M | $4.71M |
| 2015-12-31 | Reported | (m) | $51.17M | (m) | (m) | (m) | $15.01M | $50.92M | $337.47M | $27.44M | $303.09M | $14.65M |
| 2014-12-31 | Reported | (m) | $52.79M | (m) | (m) | (m) | $15.41M | $65.18M | $336.00M | $27.78M | $323.49M | $14.48M |
| 2013-12-31 | Reported | (m) | $56.51M | (m) | (m) | (m) | $18.45M | $80.95M | $350.29M | $25.83M | $330.08M | $14.69M |
| 2012-12-31 | Reported | (m) | $65.21M | (m) | (m) | (m) | $21.53M | $95.20M | $361.30M | $28.21M | $302.47M | $19.00M |
| 2011-12-31 | Reported | (m) | $8.27M | (m) | (m) | (m) | $17.55M | $102.99M | $350.14M | $28.65M | $276.62M | -$3.06M |
| 2010-12-31 | Reported | (m) | $57.09M | (m) | (m) | (m) | $14.73M | $38.24M | $348.34M | $29.65M | $276.46M | $15.31M |
| 2009-12-31 | Reported | (m) | $28.27M | (m) | (m) | (m) | $21.44M | $25.03M | $357.41M | $31.84M | $266.31M | $6.02M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |